bridger logo.jpg
Bridger Aerospace Announces Schedule for its First Quarter 2024 Earnings Release and Conference Call
May 07, 2024 08:03 ET | Bridger Aerospace Group Holdings, Inc.
BELGRADE, Mont., May 07, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting...
Ardelyx-Logo-RGB.png
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
May 07, 2024 08:01 ET | Ardelyx, Inc.
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class...
Zscaler-Logo-TM-Blue-RGB-20Dec2016.jpg
Zscaler Joins Forces with Google to Offer Unparalleled Zero Trust Data and Threat Protection
May 07, 2024 08:01 ET | Zscaler, Inc.
SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, has collaborated with Google on a joint zero trust architecture with Chrome Enterprise....
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
May 07, 2024 08:01 ET | Mainz BioMed NV
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
GLDDcorp_Bullseye (4).jpg
Great Lakes Reports First Quarter 2024 Results
May 07, 2024 08:00 ET | Great Lakes Dredge & Dock Corporation
 First quarter net income of $21.0 millionFirst quarter adjusted EBITDA of $42.9 millionDredging backlog of $879.4 million at March 31, 2024 HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Great Lakes...
NuvectisPharma_Logos_FINAL_Full_Color.png
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
May 07, 2024 08:00 ET | Nuvectis Pharma, Inc.
Encouraging preliminary data announced from the NXP800 Phase 1b study in platinum resistant, ARID1a-mutated ovarian cancer, a program granted Fast Track Designation by the US FDAData presented at the...
gcm.jpg
GCM Grosvenor Reports First Quarter 2024 Earnings Results
May 07, 2024 08:00 ET | GCM Grosvenor
CHICAGO, May 07, 2024 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG) today reported its results for the first quarter 2024, which have been posted to the Public Shareholders section of GCM...
DareBio_Stacked_Fullcolor_RGB.jpg
Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and Webcast on May 14, 2024
May 07, 2024 08:00 ET | Daré Bioscience, Inc.
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30...
edited.png
Golden Sun Health Technology Group Limited Regains Compliance with Nasdaq Continued Listing Requirement
May 07, 2024 08:00 ET | Golden Sun Health Technology Group Limited
Shanghai, China, May 07, 2024 (GLOBE NEWSWIRE) -- Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited (the “Company” or “Golden Sun”) (Nasdaq: GSUN), a...
nuwellis.jpg
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
May 07, 2024 08:00 ET | Nuwellis, Inc.
MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...